Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H21ClN2OS.ClH |
| Molecular Weight | 397.362 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN(CC)CCC(=O)N1C2=CC(Cl)=CC=C2SC3=C1C=CC=C3
InChI
InChIKey=QELDTSNVBZMBTQ-UHFFFAOYSA-N
InChI=1S/C19H21ClN2OS.ClH/c1-3-21(4-2)12-11-19(23)22-15-7-5-6-8-17(15)24-18-10-9-14(20)13-16(18)22;/h5-10,13H,3-4,11-12H2,1-2H3;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C19H21ClN2OS |
| Molecular Weight | 360.901 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Chloracyzine is phenothiazine derivative with vasodilatory activity. Chloracyzine produced a decrease in myocardial oxygen consumption accompanied by a reduction in coronary blood flow preceded by transient coronary dilatation. Chloracyzine produced an insignificant increase in arterial pressure; heart rate increased slightly in the open-chest experiments but not in the isolated heart. It is suggested that reduced oxygen uptake after chloracyzine is realized through improved efficiency in the use of oxygen.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:41:20 GMT 2025
by
admin
on
Mon Mar 31 21:41:20 GMT 2025
|
| Record UNII |
3R20PI460D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3R20PI460D
Created by
admin on Mon Mar 31 21:41:20 GMT 2025 , Edited by admin on Mon Mar 31 21:41:20 GMT 2025
|
PRIMARY | |||
|
DTXSID40909008
Created by
admin on Mon Mar 31 21:41:20 GMT 2025 , Edited by admin on Mon Mar 31 21:41:20 GMT 2025
|
PRIMARY | |||
|
m3338
Created by
admin on Mon Mar 31 21:41:20 GMT 2025 , Edited by admin on Mon Mar 31 21:41:20 GMT 2025
|
PRIMARY | Merck Index | ||
|
1045-82-5
Created by
admin on Mon Mar 31 21:41:20 GMT 2025 , Edited by admin on Mon Mar 31 21:41:20 GMT 2025
|
PRIMARY | |||
|
213-877-1
Created by
admin on Mon Mar 31 21:41:20 GMT 2025 , Edited by admin on Mon Mar 31 21:41:20 GMT 2025
|
PRIMARY | |||
|
160559
Created by
admin on Mon Mar 31 21:41:20 GMT 2025 , Edited by admin on Mon Mar 31 21:41:20 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |